{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:27:49Z","timestamp":1790861269580,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/mp.2016.230","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T04:08:11Z","timestamp":1483416491000},"page":"1327-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":205,"title":["Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding"],"prefix":"10.1038","volume":"22","author":[{"given":"I","family":"Moreno-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Edwards III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Salvadores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shahnawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Diaz-Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"BFmp2016230_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","volume":"75","author":"F Chiti","year":"2006","unstructured":"Chiti F, Dobson CM . Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75: 333\u2013366.","journal-title":"Annu Rev Biochem"},{"key":"BFmp2016230_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C . Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4: 49\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"BFmp2016230_CR3","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM . Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 2010; 30: 7281\u20137289.","journal-title":"J Neurosci"},{"key":"BFmp2016230_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1385\/NMM:4:1-2:49","volume":"4","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Lee VM, Trojanowski JQ . Interactions of amyloidogenic proteins. Neuromolecular Med 2003; 4: 49\u201358.","journal-title":"Neuromolecular Med"},{"key":"BFmp2016230_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C et al. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol 2015; 129: 729\u2013748.","journal-title":"Acta Neuropathol"},{"key":"BFmp2016230_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000161560","volume":"26","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S et al. Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord 2008; 26: 343\u2013350.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"BFmp2016230_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","volume":"16","author":"WW Barker","year":"2002","unstructured":"Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002; 16: 203\u2013212.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BFmp2016230_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2014.08.008","volume":"71","author":"MJ Guerrero-Munoz","year":"2014","unstructured":"Guerrero-Munoz MJ, Castillo-Carranza DL, Krishnamurthy S, Paulucci-Holthauzen AA, Sengupta U, Lasagna-Reeves CA et al. Amyloid-beta oligomers as a template for secondary amyloidosis in Alzheimer's disease. Neurobiol Dis 2014; 71: 14\u201323.","journal-title":"Neurobiol Dis"},{"key":"BFmp2016230_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"K Jackson","year":"2013","unstructured":"Jackson K, Barisone GA, Diaz E, Jin LW, Decarli C, Despa F . Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol 2013; 74: 517\u2013526.","journal-title":"Ann Neurol"},{"key":"BFmp2016230_CR10","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","volume":"31","author":"J Miklossy","year":"2010","unstructured":"Miklossy J, Qing H, Radenovic A, Kis A, Vileno B, Laszlo F et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 2010; 31: 1503\u20131515.","journal-title":"Neurobiol Aging"},{"key":"BFmp2016230_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P . Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64\u201374.","journal-title":"Lancet Neurol"},{"key":"BFmp2016230_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R . Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570\u2013575.","journal-title":"Arch Neurol"},{"key":"BFmp2016230_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-2009-1011","volume":"16","author":"D Kopf","year":"2009","unstructured":"Kopf D, Frolich L . Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 2009; 16: 677\u2013685.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2016230_CR14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM . Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999; 53: 1937\u20131942.","journal-title":"Neurology"},{"key":"BFmp2016230_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1192\/bjp.bp.109.067942","volume":"196","author":"L Velayudhan","year":"2010","unstructured":"Velayudhan L, Poppe M, Archer N, Proitsi P, Brown RG, Lovestone S . Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry 2010; 196: 36\u201340.","journal-title":"Br J Psychiatry"},{"key":"BFmp2016230_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.neurobiolaging.2013.09.033","volume":"35","author":"JK Morris","year":"2014","unstructured":"Morris JK, Vidoni ED, Honea RA, Burns JM . Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging 2014; 35: 585\u2013589.","journal-title":"Neurobiol Aging"},{"key":"BFmp2016230_CR17","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC . Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004; 53: 474\u2013481.","journal-title":"Diabetes"},{"key":"BFmp2016230_CR18","doi-asserted-by":"publisher","first-page":"e88063","DOI":"10.1371\/journal.pone.0088063","volume":"9","author":"WQ Qiu","year":"2014","unstructured":"Qiu WQ, Wallack M, Dean M, Liebson E, Mwamburi M, Zhu H . Association between amylin and amyloid-beta peptides in plasma in the context of apolipoprotein E4 allele. PLoS One 2014; 9: e88063.","journal-title":"PLoS One"},{"key":"BFmp2016230_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1042\/BST0331041","volume":"33","author":"GJ Biessels","year":"2005","unstructured":"Biessels GJ, Kappelle LJ . Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005; 33: 1041\u20131044.","journal-title":"Biochem Soc Trans"},{"key":"BFmp2016230_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","volume":"73","author":"JT Jarrett","year":"1993","unstructured":"Jarrett JT, Lansbury PT Jr. . Seeding \"one-dimensional crystallization\" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993; 73: 1055\u20131058.","journal-title":"Cell"},{"key":"BFmp2016230_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tibs.2006.01.002","volume":"31","author":"C Soto","year":"2006","unstructured":"Soto C, Estrada L, Castilla J . Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem Sci 2006; 31: 150\u2013155.","journal-title":"Trends Biochem Sci"},{"key":"BFmp2016230_CR22","doi-asserted-by":"publisher","first-page":"e1003537","DOI":"10.1371\/journal.ppat.1003537","volume":"9","author":"R Morales","year":"2013","unstructured":"Morales R, Moreno-Gonzalez I, Soto C . Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog 2013; 9: e1003537.","journal-title":"PLoS Pathog"},{"key":"BFmp2016230_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2353\/ajpath.2007.060576","volume":"171","author":"J Yan","year":"2007","unstructured":"Yan J, Fu X, Ge F, Zhang B, Yao J, Zhang H et al. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am J Pathol 2007; 171: 172\u2013180.","journal-title":"Am J Pathol"},{"key":"BFmp2016230_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1074\/jbc.M609269200","volume":"282","author":"YA Vitrenko","year":"2007","unstructured":"Vitrenko YA, Gracheva EO, Richmond JE, Liebman SW . Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J Biol Chem 2007; 282: 1779\u20131787.","journal-title":"J Biol Chem"},{"key":"BFmp2016230_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1110\/ps.04707004","volume":"13","author":"MR Krebs","year":"2004","unstructured":"Krebs MR, Morozova-Roche LA, Daniel K, Robinson CV, Dobson CM . Observation of sequence specificity in the seeding of protein amyloid fibrils. Protein Sci 2004; 13: 1933\u20131938.","journal-title":"Protein Sci"},{"key":"BFmp2016230_CR26","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1074\/jbc.M311300200","volume":"279","author":"B O'Nuallain","year":"2004","unstructured":"O'Nuallain B, Williams AD, Westermark P, Wetzel R . Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 2004; 279: 17490\u201317499.","journal-title":"J Biol Chem"},{"key":"BFmp2016230_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bbadis.2014.01.002","volume":"1842","author":"K Ono","year":"2014","unstructured":"Ono K, Takahashi R, Ikeda T, Mizuguchi M, Hamaguchi T, Yamada M . Exogenous amyloidogenic proteins function as seeds in amyloid beta-protein aggregation. Biochim Biophys Acta 2014; 1842: 646\u2013653.","journal-title":"Biochim Biophys Acta"},{"key":"BFmp2016230_CR28","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1002\/anie.200904902","volume":"49","author":"E Andreetto","year":"2010","unstructured":"Andreetto E, Yan LM, Tatarek-Nossol M, Velkova A, Frank R, Kapurniotu A . Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. Angew Chem Int Ed Engl 2010; 49: 3081\u20133085.","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFmp2016230_CR29","doi-asserted-by":"publisher","first-page":"11665","DOI":"10.1074\/jbc.M111.282533","volume":"287","author":"M Shahnawaz","year":"2012","unstructured":"Shahnawaz M, Soto C . Microcin amyloid fibrils are a reservoir of toxic oligomeric species. J Biol Chem 2012; 287: 11665\u201311676.","journal-title":"J Biol Chem"},{"key":"BFmp2016230_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996; 274: 99\u2013102.","journal-title":"Science"},{"key":"BFmp2016230_CR31","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 1996; 93: 7283\u20137288.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2016230_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","volume":"12","author":"GH Tesch","year":"2007","unstructured":"Tesch GH, Allen TJ . Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 2007; 12: 261\u2013266.","journal-title":"Nephrology (Carlton)"},{"key":"BFmp2016230_CR33","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.3233\/JAD-2012-111433","volume":"30","author":"JA Luchsinger","year":"2012","unstructured":"Luchsinger JA . Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis 2012; 30: S185\u2013S198.","journal-title":"J Alzheimers Dis"},{"key":"BFmp2016230_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1471-4159.2012.07668.x","volume":"121","author":"N Yamamoto","year":"2012","unstructured":"Yamamoto N, Matsubara T, Sobue K, Tanida M, Kasahara R, Naruse K et al. Brain insulin resistance accelerates Abeta fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes. J Neurochem 2012; 121: 619\u2013628.","journal-title":"J Neurochem"},{"key":"BFmp2016230_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diabet.2010.03.001","volume":"36","author":"I Bourdel-Marchasson","year":"2010","unstructured":"Bourdel-Marchasson I, Lapre E, Laksir H, Puget E . Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab 2010; 36: 173\u2013181.","journal-title":"Diabetes Metab"},{"key":"BFmp2016230_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","volume":"70","author":"MA Reger","year":"2008","unstructured":"Reger MA, Watson GS, Green PS, Wilkinson CW, Baker LD, Cholerton B et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008; 70: 440\u2013448.","journal-title":"Neurology"},{"key":"BFmp2016230_CR37","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1037\/a0017722","volume":"123","author":"V Haj-ali","year":"2009","unstructured":"Haj-ali V, Mohaddes G, Babri SH . Intracerebroventricular insulin improves spatial learning and memory in male Wistar rats. Behav Neurosci 2009; 123: 1309\u20131314.","journal-title":"Behav Neurosci"},{"key":"BFmp2016230_CR38","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1210\/en.2009-0695","volume":"150","author":"B Kim","year":"2009","unstructured":"Kim B, Backus C, Oh S, Hayes JM, Feldman EL . Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology 2009; 150: 5294\u20135301.","journal-title":"Endocrinology"},{"key":"BFmp2016230_CR39","doi-asserted-by":"publisher","first-page":"e7917","DOI":"10.1371\/journal.pone.0007917","volume":"4","author":"YD Ke","year":"2009","unstructured":"Ke YD, Delerue F, Gladbach A, Gotz J, Ittner LM . Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 2009; 4: e7917.","journal-title":"PLoS One"},{"key":"BFmp2016230_CR40","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"L Escribano","year":"2010","unstructured":"Escribano L, Simon AM, Gimeno E, Cuadrado-Tejedor M, Lopez de MR, Garcia-Osta A et al. Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 2010; 35: 1593\u20131604.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2016230_CR41","doi-asserted-by":"publisher","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","volume":"31","author":"PL McClean","year":"2011","unstructured":"McClean PL, Parthsarathy V, Faivre E, Holscher C . The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 2011; 31: 6587\u20136594.","journal-title":"J Neurosci"},{"key":"BFmp2016230_CR42","first-page":"950","volume":"13","author":"GS Watson","year":"2005","unstructured":"Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005; 13: 950\u2013958.","journal-title":"Am J Geriatr Psychiatry"},{"key":"BFmp2016230_CR43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","volume":"6","author":"ME Risner","year":"2006","unstructured":"Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 2006; 6: 246\u2013254.","journal-title":"Pharmacogenomics J"},{"key":"BFmp2016230_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1532-5415.2009.02067.x","volume":"57","author":"H Hanyu","year":"2009","unstructured":"Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T . Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus. J Am Geriatr Soc 2009; 57: 177\u2013179.","journal-title":"J Am Geriatr Soc"},{"key":"BFmp2016230_CR45","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson ME, Paulsson JF, Schultz SW, Ingelsson M, Westermark P, Westermark GT . In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Am J Pathol 2015; 185: 834\u2013846.","journal-title":"Am J Pathol"},{"key":"BFmp2016230_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC . The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999; 48: 491\u2013498.","journal-title":"Diabetes"},{"key":"BFmp2016230_CR47","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 1998; 95: 6448\u20136453.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2016230_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1326-9-30","volume":"9","author":"S Srodulski","year":"2014","unstructured":"Srodulski S, Sharma S, Bachstetter AB, Brelsfoard JM, Pascual C, Xie XS et al. Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin. Mol Neurodegener 2014; 9: 30.","journal-title":"Mol Neurodegener"},{"key":"BFmp2016230_CR49","doi-asserted-by":"publisher","first-page":"e0117362","DOI":"10.1371\/journal.pone.0117362","volume":"10","author":"S Okabayashi","year":"2015","unstructured":"Okabayashi S, Shimozawa N, Yasutomi Y, Yanagisawa K, Kimura N . Diabetes mellitus accelerates Abeta pathology in brain accompanied by enhanced GAbeta generation in nonhuman primates. PLoS One 2015; 10: e0117362.","journal-title":"PLoS One"},{"key":"BFmp2016230_CR50","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00018-009-9070-1","volume":"66","author":"J Gotz","year":"2009","unstructured":"Gotz J, Ittner LM, Lim YA . Common features between diabetes mellitus and Alzheimer's disease. Cell Mol Life Sci 2009; 66: 1321\u20131325.","journal-title":"Cell Mol Life Sci"},{"key":"BFmp2016230_CR51","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.expneurol.2009.11.005","volume":"223","author":"CG Jolivalt","year":"2010","unstructured":"Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E . Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 2010; 223: 422\u2013431.","journal-title":"Exp Neurol"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2016230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2016.230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/mp2016230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:50:12Z","timestamp":1648767012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2016230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,3]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFmp2016230"],"URL":"https:\/\/doi.org\/10.1038\/mp.2016.230","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727163170.793572338","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,3]]},"assertion":[{"value":"18 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}